Toho Holdings Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Toho Holdings Company Limited with three other
drug stores in Asia:
Vital KSK Holdings Incorporation
sales of 621.04 billion Japanese Yen [US$5.38 billion]
of which 95%
was Pharmaceuticals Sales),
Hokuyaku Takeyama Holdings, Inc
(225.15 billion Japanese Yen [US$1.95 billion]
of which 72%
was Pharmaceutical Business), and
Suzuken Co., Ltd.
(2.23 trillion Japanese Yen [US$19.30 billion]
of which 93%
was Pharmaceutical Wholesale Business).
During the year ended March of 2016, sales at
Toho Holdings Company Limited were ¥1.31 trillion (US$11.33 billion).
increase of 12.6%
versus 2015, when the company's sales were ¥1.16 trillion.
Sales of Institutional Support for Clinical Trial saw an increase
that was more than double the company's growth rate: sales were up
43.5% in 2016, from
¥370.00 million to ¥531.00 million.
Not all segments of Toho Holdings Company Limited experienced an increase in sales in 2016:
sales of Information Equipment Sales fell 13.5% to ¥1.21 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).